Spontaneous human lymphocyte-mediated cytotoxicity against tumor target cells. IX. The quantitation of natural killer cell activity

Journal of Clinical Immunology

Volumn 1, Issue 1, 1981, Pages 51-63

  Pross, Hugh F ^a   Baines, Malcolm G ^a   Rubin, Peter ^a   Shragge, Peter ^a   Patterson, Michael S ^a  

^a QUEEN S UNIVERSITY   (Canada)

Author keywords

chromium release; Human natural killer cells

Indexed keywords

BLOOD AND HEMOPOIETIC SYSTEM; ETIOLOGY; HUMAN CELL; IN VITRO STUDY; LYMPHOCYTOTOXICITY; NATURAL KILLER CELL; NORMAL HUMAN; RADIOIMMUNOASSAY; TARGET CELL DESTRUCTION; TUMOR CELL;

ANIMALS; CELL LINE; CHROMIUM RADIOISOTOPES; CYTOTOXICITY TESTS, IMMUNOLOGIC; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; FEMALE; HUMANS; LYMPHOCYTES; MALE; MATHEMATICS; MICE; TIME FACTORS;

EID: 0019724725     PISSN: 02719142     EISSN: 15732592     Source Type: Journal    
DOI: 10.1007/BF00915477     Document Type: Article

References (47)

1. Spontaneous human lymphocyte-mediated cytotoxicity against tumor target cells. VI. A brief review
2. Natural killer cells: Characteristics and regulation of activity
3. Spontaneous human lymphocyte-mediated cytotoxicity against tumor target cells. IV. The suppressive effect of normal pregnancy
4. Spontaneous human lymphocyte-mediated cytotoxicity against tumor target cells. VIII. Characteristics of normal lymphocytes showing consistently high or low natural killer (NK) cell activity
5. HLA-related control of spontaneous and antibody-dependent cell-mediated cytotoxic activity in humans
6. Low natural-killer-cell activity in familial melanoma patients and their relatives
7. Spontaneous human lymphocyte-mediated cytotoxicity against target cells. I. The effect of malignant disease
8. Decline of natural non-selective cell-mediated cytotoxicity in patients with tumor progression
9. Cytotoxicity of non-T vs T-lymphocytes from melanoma patients and healthy donors on short- and long-term cultured melanoma cells
10. Lymphocyte mediated natural cytotoxicity in neoplasia
11. Cytotoxic effector cells specific for B cell lines transformed by Epstein-Barr virus are present in patients with infectious mononucleosis
12. Spontaneous human lymphocyte-mediated cytotoxicity against tumor target cells. VII. The effect of immunodeficiency disease
13. Natural killing in immunodeficient patients
14. Natural killer effects of corticosteroids on activity in systemic lupus erythematosus
15. Dysfunction of natural killer cells in multiple sclerosis: A possible pathogenetic factor
16. Comparison of the effector cells in human spontaneous cellular cytotoxicity and antibody-dependent cellular cytotoxicity: Differential sensitivity of effector cells to in vivo and in vitro corticosteroids
17. Effects of Corynebacterium parvum and BCG therapy on immune parameters in patients with disseminated melanoma. A sequential study over 28 days
18. Interferon and spontaneous cytotoxicity in man
19. Analysis of cytotoxic effector cell function in patients with leukemia or aplastic anemia before and after marrow transplantation
20. Association between pre-transplant natural kill and graftversus-host disease after stem-cell transplantation
21. Colloidal chemistry and immunology
22. Quantitative assay of the lytic action of immune lymphoid cells on51Cr-labelled allogeneic target cells in vitro: Inhibition by isoantibody and by drugs
23. Kinetic analysis of target cell destruction by effector T cells. I. Delineation of parameters related to the frequency and lytic efficiency of killer cells
24. Cytotoxic activity of human lymphocytes: Quantitative analysis of T cell and K cell cytotoxicity, revealing enzyme-like kinetics
25. Spontaneous cytotoxicity of cultured human cell lines mediated by normal peripheral blood lymphocytes. III. Kinetic parameters
26. Separation of leukocytes from blood and bone marrow
27. Differential effects of human granulocytes and lymphocytes on human fibroblasts in vitro
28. Surface markers on human B and T lymphocytes. VI. Cytotoxicity against cell lines as a functional marker for lymphocyte subpopulations
29. Natural killer cells in tumor-bearing patients
30. Antibiotic control of mycoplasma in tissue culture
31. High nonspecific reactivity of normal lymphocytes against mycoplasma-infected target cells in cytotoxicity assays
32. Cytotoxicity of a factor isolated from human spleen
33. Continuous growth and differentiation of human myeloid leukemic cells in suspension culture
34. Quantitative analysis of the51Cr release cytotoxicity assay for cytotoxic lymphocytes
35. A modified51Cr release assay for cytotoxic lymphocytes
36. Quantitation of K cells
37. Lymphocyte antibody lymphocytolytic interaction (LALI) with special emphasis on HL-A
38. Spontaneous human lymphocyte-mediated cytotoxicity against tumor target cells. V. The role of serum-derived heterologous membrane antigens
39. Cytotoxic lymphocytes from normal donors. A functional marker of human non-T lymphocytes
40. Natural cytotoxicity of mouse, rat, and human lymphocytes against heterologous target cells
41. Characterization of cells that suppress the cytotoxic activity of T lymphocytes. I. Quantitative measurement of inhibitor cells
42. Characteristics of human natural killer cells
43. Cryopreservation of human lymphocyte function as measured by in vitro assays
44. Statistical Analysis and selection of baseline controls in cytotoxicity assays